...
机译:T1期或T2期肾细胞癌腹腔镜根治性肾切除术后标本切除的安全性和有效性的多机构研究
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.;
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.;
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.;
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.;
Department of Urology, University of Michigan Medical Center, Ann Arbor, Michigan.;
Department of Urology, University of California Irvine Medical Center, Orange, California.;
Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.;
机译:腹腔镜根治性肾切除术后标本粉碎的安全性和有效性的多机构研究,用于临床T1或T2期肾细胞癌。
机译:腹腔镜根治性肾切除术和开放性根治性肾切除术治疗病理分期明确的T1和T2肾细胞癌的比较-具有清晰的细胞组织学特征:一项多机构研究。
机译:腹腔镜根治性肾切除术与手动标本切除术治疗cT1期肾细胞癌的安全性和有效性
机译:腹腔镜激进切除术治疗直肠癌的疗效和安全性研究
机译:肾细胞癌在末期肾病患者:制度综述
机译:肥胖是腹腔镜根治性肾切除术对T2而非T1肾细胞癌的不利因素
机译:临床T1期或T2期肾细胞癌腹腔镜肾癌根治术后标本粉碎安全性和有效性的多机构研究